# MBX Biosciences, Inc.: filings

MBX · Nasdaq · CIK 1776111 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mbx.md) · [Financials](/companies/mbx/financials.md) · [Filings](/companies/mbx/filings.md) · [Insiders](/companies/mbx/insiders.md)

## Reports and events: 54 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 69, 8-K 28, 3 26, 144 17, SCHEDULE 13G/A 10, CORRESP 8, SCHEDULE 13D/A 8, 10-Q 6, UPLOAD 5, SC 13D 4, SC 13G 4, D 3, DEFA14A 3, EFFECT 3, S-8 3, 10-K 2, 4/A 2, ARS 2, DEF 14A 2, DRS 2, DRS/A 2, DRSLTR 2, S-1 2, S-1/A 2, S-1MEF 2, SCHEDULE 13G 2, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, D/A 1, S-3 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 12:11 ET | [8-K](/filings/0001193125-26-428367.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-428367 |
| 2026-08-27 | 12:34 ET | [8-K](/filings/0001193125-26-369674.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-369674 |
| 2026-08-10 | 21:35 ET | [SCHEDULE 13D/A](/filings/0001231919-26-000851.md) | Ownership report, active investor, amended | 0001231919-26-000851 |
| 2026-08-10 | 20:44 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000776.md) | Ownership report, active investor, amended | 0000947871-26-000776 |
| 2026-08-06 | 12:06 ET | [10-Q](/filings/0001193125-26-336849.md) | Quarterly report, period 2026-06-30 | 0001193125-26-336849 |
| 2026-08-06 | 12:03 ET | [8-K](/filings/0001193125-26-336841.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336841 |
| 2026-07-13 | 20:46 ET | [8-K](/filings/0001193125-26-302098.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-302098 |
| 2026-06-12 | 11:05 ET | [8-K](/filings/0001193125-26-268477.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-268477 |
| 2026-06-05 | 11:52 ET | [8-K](/filings/0001193125-26-258417.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-258417 |
| 2026-05-11 | 11:04 ET | [8-K](/filings/0001193125-26-215676.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-215676 |
| 2026-05-07 | 14:33 ET | [8-K](/filings/0001193125-26-210825.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210825 |
| 2026-05-07 | 13:03 ET | [10-Q](/filings/0001193125-26-210593.md) | Quarterly report, period 2026-03-31 | 0001193125-26-210593 |
| 2026-04-22 | 12:04 ET | [DEF 14A](/filings/0001193125-26-168536.md) | Proxy statement, period 2026-04-22 | 0001193125-26-168536 |
| 2026-03-12 | 12:05 ET | [10-K](/filings/0001193125-26-103121.md) | Annual report, period 2025-12-31 | 0001193125-26-103121 |
| 2026-03-12 | 12:02 ET | [8-K](/filings/0001193125-26-103118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-103118 |
| 2026-03-09 | 12:03 ET | [8-K](/filings/0001193125-26-097611.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-097611 |
| 2026-02-27 | 12:54 ET | [8-K](/filings/0001193125-26-079286.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-079286 |
| 2026-02-11 | 23:42 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000114.md) | Ownership report, active investor, amended | 0000947871-26-000114 |
| 2026-02-05 | 21:27 ET | [8-K](/filings/0001193125-26-039475.md) | 8.01 Other events | 0001193125-26-039475 |
| 2026-01-22 | 13:04 ET | [8-K](/filings/0001193125-26-018700.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-018700 |
| 2026-01-12 | 11:02 ET | [8-K](/filings/0001193125-26-009642.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009642 |
| 2025-11-10 | 22:08 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000781.md) | Ownership report, active investor, amended | 0001072613-25-000781 |
| 2025-11-06 | 13:08 ET | [10-Q](/filings/0001193125-25-268148.md) | Quarterly report, period 2025-09-30 | 0001193125-25-268148 |
| 2025-11-06 | 13:06 ET | [8-K](/filings/0001193125-25-268146.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001193125-25-268146 |
| 2025-09-30 | 23:06 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000872.md) | Ownership report, active investor, amended | 0000947871-25-000872 |
| 2025-09-30 | 22:15 ET | [SCHEDULE 13D/A](/filings/0001876200-25-000004.md) | Ownership report, active investor, amended | 0001876200-25-000004 |
| 2025-09-30 | 21:01 ET | [SCHEDULE 13D/A](/filings/0001863769-25-000010.md) | Ownership report, active investor, amended | 0001863769-25-000010 |
| 2025-09-26 | 20:01 ET | [8-K](/filings/0001193125-25-220432.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-220432 |
| 2025-09-22 | 20:12 ET | [S-1](/filings/0001193125-25-211320.md) | Registration statement | 0001193125-25-211320 |
| 2025-09-22 | 12:00 ET | [8-K](/filings/0001193125-25-210049.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-210049 |
| 2025-09-04 | 12:09 ET | [8-K](/filings/0001776111-25-000007.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001776111-25-000007 |
| 2025-08-20 | 21:23 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022503.md) | Ownership report, active investor, amended | 0001415889-25-022503 |
| 2025-08-07 | 12:46 ET | [10-Q](/filings/0000950170-25-104619.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104619 |
| 2025-08-07 | 12:10 ET | [8-K](/filings/0000950170-25-104602.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104602 |
| 2025-06-16 | 12:02 ET | [8-K](/filings/0000950170-25-086546.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-086546 |
| 2025-06-09 | 11:59 ET | [8-K](/filings/0000950170-25-083447.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-083447 |
| 2025-06-06 | 11:59 ET | [8-K](/filings/0000950170-25-082697.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-082697 |
| 2025-05-12 | 12:19 ET | [10-Q](/filings/0000950170-25-068602.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068602 |
| 2025-05-12 | 12:11 ET | [8-K](/filings/0000950170-25-068599.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068599 |
| 2025-04-23 | 12:43 ET | [DEF 14A](/filings/0000950170-25-056978.md) | Proxy statement, period 2025-04-22 | 0000950170-25-056978 |
| 2025-04-07 | 12:11 ET | [8-K](/filings/0000950170-25-051371.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-051371 |
| 2025-03-17 | 12:14 ET | [10-K](/filings/0000950170-25-039838.md) | Annual report, period 2024-12-31 | 0000950170-25-039838 |
| 2025-03-17 | 12:07 ET | [8-K](/filings/0000950170-25-039837.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-039837 |
| 2025-01-07 | 12:21 ET | [8-K](/filings/0000950170-25-002555.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-002555 |
| 2024-11-07 | 13:31 ET | [10-Q](/filings/0000950170-24-122840.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122840 |
| 2024-11-07 | 13:08 ET | [8-K](/filings/0000950170-24-122824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122824 |
| 2024-09-23 | 22:07 ET | [SC 13D](/filings/0001104659-24-102144.md) | Ownership report, active investor | 0001104659-24-102144 |
| 2024-09-23 | 22:05 ET | [SC 13D](/filings/0001072613-24-000721.md) | Ownership report, active investor | 0001072613-24-000721 |
| 2024-09-23 | 20:34 ET | [SC 13D](/filings/0000947871-24-000767.md) | Ownership report, active investor | 0000947871-24-000767 |
| 2024-09-23 | 14:48 ET | [SC 13D](/filings/0001193125-24-223402.md) | Ownership report, active investor | 0001193125-24-223402 |

Page 1 of 2. [Older](/companies/mbx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.